z-logo
open-access-imgOpen Access
Adiponectin Is a Link Among Inflammation, Insulin Resistance, and High‐Density Lipoprotein Cholesterol But Is Not Associated With Paraoxonase Activity in Premenopausal Women
Author(s) -
CetinalpDemircan Pinar,
Bekpinar Selda,
Gurdol Figen,
Orhan Yusuf
Publication year - 2009
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/j.1559-4572.2008.00048.x
Subject(s) - adiponectin , medicine , endocrinology , insulin resistance , body mass index , high density lipoprotein , homeostatic model assessment , lipoprotein , paraoxonase , cholesterol , insulin , oxidative stress
The aim of this study was to evaluate whether insulin sensitivity, inflammatory response, and plasma lipid profile are associated with circulating adiponectin levels in nondiabetic healthy women. The authors also assessed whether adiponectin has any effect on high‐density lipoprotein cholesterol–linked paraoxonase 1 (PON‐1) activity and on the susceptibility of low‐density lipoproteins to oxidation. Plasma adiponectin was measured in 91 nondiabetic premenopausal women, and the patients were then divided into quartiles. Circulating adiponectin was found to be associated with body mass index ( r =.55, P <.001). After adjustment for body mass index, adiponectin showed an inverse correlation with the homeostasis model assessment of insulin resistance (HOMA‐IR) ( r =−.41, P <.001) and a positive correlation with high‐density lipoprotein cholesterol ( r =.43, P <.001). In linear regression analysis, HOMA‐IR, tumor necrosis factor α, and high‐density lipoprotein cholesterol levels were found to be independently associated with adiponectin. However, high‐density lipoprotein cholesterol–linked PON‐1 activity and the susceptibility of low‐density lipoproteins to in vitro oxidation did not seem to be related to plasma adiponectin concentrations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here